Division of Cardiac, Thoracic, Transplantation and Vascular Surgery, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Germany,
Adv Biochem Eng Biotechnol. 2012;126:105-16. doi: 10.1007/10_2011_109.
The idea to create the concept of cardiovascular "tissue engineering" is based on the recognition that until then all known allogeneic/xenogeneic biological or alloplastic implant materials were associated with shortcomings, which led to graft deterioration, degradation and finally destruction. Thus, it aims to develop viable cardiovascular structures, e.g. heart valves, myocardium or blood vessels, which ideally demonstrate mechanisms of remodeling and self-repair, a high microbiological resistance, complete immunological integrity and a functional endothelial cell layer to guarantee physiological hemostasis. In our current review we aim to identify basic limitations of previous concepts, explain why the use of decellularized matrices was a logical consequence and which limitations still exist.
创建心血管“组织工程”概念的想法基于这样一种认识,即直到那时,所有已知的同种异体/异种生物或全合成植入材料都存在缺陷,导致移植物恶化、降解,最终破坏。因此,它旨在开发可行的心血管结构,例如心脏瓣膜、心肌或血管,这些结构理想地展示出重塑和自我修复的机制、高微生物抗性、完整的免疫完整性和功能齐全的内皮细胞层,以保证生理止血。在我们目前的综述中,我们旨在确定以前概念的基本局限性,解释为什么使用去细胞基质是合乎逻辑的结果,以及仍然存在哪些局限性。